Division of Medical Sciences, University of Victoria, Victoria, BC, Canada.
Vancouver Island Health Authority, Victoria, BC, Canada.
J Alzheimers Dis. 2024;100(4):1099-1119. doi: 10.3233/JAD-240088.
Alzheimer's disease (AD) accounts for most dementia cases, but we lack a complete understanding of the mechanisms responsible for the core pathology associated with the disease (e.g., amyloid plaque and neurofibrillary tangles). Inflammation has been identified as a key contributor of AD pathology, with recent evidence pointing towards Reelin dysregulation as being associated with inflammation. Here we describe Reelin signaling and outline existing research involving Reelin signaling in AD and inflammation. Research is described pertaining to the inflammatory and immunological functions of Reelin before we propose a mechanism through which inflammation renders Reelin susceptible to dysregulation resulting in the induction and exacerbation of AD pathology. Based on this hypothesis, it is predicted that disorders of both inflammation (including peripheral inflammation and neuroinflammation) and Reelin dysregulation (including disorders associated with upregulated Reelin expression and disorders of Reelin downregulation) have elevated risk of developing AD. We conclude with a description of AD risk in various disorders involving Reelin dysregulation and inflammation.
阿尔茨海默病(AD)占大多数痴呆病例,但我们对与疾病相关的核心病理学(例如淀粉样斑块和神经原纤维缠结)负责的机制缺乏全面了解。炎症已被确定为 AD 病理学的关键因素,最近的证据表明 Reelin 失调与炎症有关。在这里,我们描述了 Reelin 信号,并概述了 AD 和炎症中 Reelin 信号的现有研究。在我们提出一种机制之前,我们描述了 Reelin 的炎症和免疫功能,该机制通过炎症使 Reelin 易于失调,从而导致 AD 病理学的诱导和加剧。基于这一假设,可以预测炎症(包括外周炎症和神经炎症)和 Reelin 失调(包括与 Reelin 表达上调相关的疾病和 Reelin 下调的疾病)紊乱的疾病发生 AD 的风险增加。我们以涉及 Reelin 失调和炎症的各种疾病的 AD 风险描述结束。